Price
Financials
Consolidated, Rs crore| Jun 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Sales | 2,238 | 2,882 | 3,091 |
| Expenses | 1,651 | 2,191 | 2,354 |
| Operating Profit | 586 | 691 | 737 |
| OPM % | 26% | 24% | 24% |
| Other Income | 30 | 27 | 59 |
| Interest | 132 | 289 | 293 |
| Depreciation | 141 | 185 | 187 |
| Profit before tax | 344 | 244 | 315 |
| Tax % | 26% | 24% | 23% |
| Net Profit | 254 | 187 | 243 |
| EPS in Rs | 2.17 | 1.51 | 1.96 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 1,813 | 3,975 | 4,806 | 6,172 | 8,242 | 10,336 |
| Expenses | 1,483 | 3,054 | 3,527 | 4,489 | 6,115 | 7,725 |
| Operating Profit | 330 | 921 | 1,279 | 1,683 | 2,127 | 2,611 |
| OPM % | 18% | 23% | 27% | 27% | 26% | 25% |
| Other Income | -47 | 293 | -48 | -86 | 134 | 111 |
| Interest | 205 | 326 | 329 | 455 | 512 | 864 |
| Depreciation | 183 | 256 | 315 | 397 | 507 | 680 |
| Profit before tax | -105 | 632 | 586 | 745 | 1,242 | 1,178 |
| Tax % | 30% | 14% | 27% | 28% | 13% | 22% |
| Net Profit | -138 | 542 | 429 | 533 | 1,082 | 917 |
| EPS in Rs | -20.12 | 71.63 | 56.73 | 70.50 | 27.65 | 7.56 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 42% | 29% | 25% | ||
| Compounded Profit Growth | % | 77% | 22% | -10% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | 16% | 16% | 13% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 69 | 76 | 76 | 76 | 77 | 236 |
| Reserves | 1,064 | 2,732 | 3,166 | 3,940 | 5,770 | 8,190 |
| Borrowings | 1,575 | 2,017 | 2,184 | 5,130 | 6,385 | 12,863 |
| Other Liabilities | 1,316 | 2,521 | 2,337 | 1,612 | 1,658 | 3,446 |
| Total Liabilities | 4,024 | 7,346 | 7,763 | 10,757 | 13,890 | 24,735 |
| Fixed Assets | 2,278 | 4,582 | 4,784 | 6,934 | 9,826 | 18,753 |
| CWIP | 412 | 1,089 | 1,033 | 1,266 | 614 | 795 |
| Investments | 551 | 768 | 1,038 | 1,121 | 1,776 | 2,675 |
| Other Assets | 784 | 907 | 908 | 1,436 | 1,675 | 2,511 |
| Total Assets | 4,024 | 7,346 | 7,763 | 10,757 | 13,890 | 24,735 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | 426 | 805 | 1,149 | 1,389 | 1,570 | 2,078 |
| Cash from Investing Activity | -188 | -1,711 | -994 | -870 | -2,544 | -7,025 |
| Cash from Financing Activity | -280 | 941 | -144 | -250 | 904 | 4,954 |
| Net Cash Flow | -42 | 34 | 12 | 268 | -70 | 8 |
| Free Cash Flow | 334 | 629 | 823 | 1,394 | 520 | 767 |
| CFO/OP | 106% | 98% | 105% | 100% | 87% | 96% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 26 | 27 | 24 | 27 | 28 | 33 |
| Inventory Days | 20 | 28 | 23 | 30 | 29 | 29 |
| Days Payable | 371 | 246 | 283 | 330 | 245 | 253 |
| Cash Conversion Cycle | -325 | -190 | -236 | -273 | -188 | -190 |
| Working Capital Days | -95 | -113 | -56 | -59 | -40 | -70 |
| ROCE % | 18% | 19% | 19% | 16% | 12% |
| Aug 2026 | |
|---|---|
| Promoters | 72.08% |
| FIIs | 3.66% |
| DIIs | 5.20% |
| Government | 0.26% |
| Public | 18.81% |
| No. of Shareholders | 3,38,074 |
Fundamentals
Market Cap₹ 98,357 Cr.
Current Price₹ 748
Stock P/E111
Book Value₹
ROCE12.1 %
ROE12.7 %
Dividend Yield0.00 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)25%
Compounded Profit Growth (TTM)-10%
Consolidated figures.
Valuation
Market capRs 91,550 Cr
Enterprise valueRs 93,405 Cr
P/E (TTM)169.00x
Price to book32.60x
Price to sales23.03x
EV / EBITDA76.95x
EV / EBIT97.52x
EV / sales23.50x
Price to cash flow113.79x
Earnings yield0.59%
Profitability
Operating margin (excl. other income)23.17%
Operating margin (incl. other income)30.53%
EBITDA margin30.53%
Pre-tax margin15.90%
Net profit margin13.63%
ROE27.50%
ROCE25.43%
ROA9.53%
ROIC (approx.)17.60%
Tax rate14.31%
Other income / net worth10.42%
Growth
Sales growth (latest year)119.23%
Per share
EPS (TTM)Rs 4.12
EPS (latest year)Rs 71.63
Book value per shareRs 21.35
Sales per shareRs 30.22
Cash flow per shareRs 6.12
Free cash flow per shareRs 5.83
Efficiency
Asset turnover0.54x
Fixed asset turnover0.87x
Inventory turnover26.04x
Inventory days14 days
Debtor days27 days
Debtors turnover13.35x
Creditor days253 days
Cash conversion cycle-190 days
Working capital days-70 days
Leverage
Total debtRs 2,017 Cr
Cash and bankRs 162 Cr
Net debtRs 1,855 Cr
Debt to equity0.72x
Net debt / EBITDA1.53x
Interest coverage2.94x
Owners' fund to total sources38.23%
Debt to assets27.45%
Cash flow
Cash from Operating Activity (latest year)Rs 805 Cr
Cash from Investing Activity (latest year)Rs -1,711 Cr
Cash from Financing Activity (latest year)Rs 941 Cr
Net Cash Flow (latest year)Rs 34 Cr
Free cash flow (latest year)Rs 767 Cr
FCFE (approx.: FCF + change in debt)Rs 1,208 Cr
Cash from ops / profit, 5 years2.00x
Sales to cash flow4.94x
Statement figures
Net sales (TTM)Rs 3,975 Cr
Net sales (latest year)Rs 3,975 Cr
Operating profit excl. other income (latest year)Rs 921 Cr
Other income (TTM)Rs 293 Cr
EBITDA (TTM)Rs 1,214 Cr
PBDT (TTM)Rs 888 Cr
Profit before tax (TTM)Rs 632 Cr
Tax (latest year)Rs 90 Cr
Net profit (TTM)Rs 542 Cr
Net profit (latest year)Rs 542 Cr
Depreciation (TTM)Rs 256 Cr
Interest (TTM)Rs 326 Cr
Cost of goods sold (latest year)Rs 2,015 Cr
Total expenditure (latest year)Rs 3,054 Cr
Total income (latest year)Rs 4,268 Cr
Share capitalRs 76 Cr
ReservesRs 2,732 Cr
Shareholders' fundsRs 2,808 Cr
Total assetsRs 7,346 Cr
Net blockRs 4,582 Cr
Capital work in progressRs 1,089 Cr
InvestmentsRs 768 Cr
ReceivablesRs 298 Cr
InventoryRs 77 Cr
Other liabilitiesRs 2,521 Cr
Shares outstanding (crore)131.54
Ownership
Promoter holding72.08%
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | MANIPALHOS | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -6.3% | -2.8% | -3.5 pts |
| 1 month | -6.8% | -6.8% | -0.0 pts |
81 mutual fund schemes hold about ₹5,449 Cr.
Over three months 0 bought more and 0 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| Invesco India Midcap Fund | 4.74% | 754 | |
| ICICI Pru Multi Asset Allocation Fund | 0.37% | 323 | |
| Invesco India Smallcap Fund | 1.70% | 267 | |
| Invesco India Large & Mid Cap Fund | 2.21% | 260 | |
| Kotak Flexi Cap Fund | 0.46% | 259 | |
| Kotak Flexi Cap Fund | 0.46% | 258 | |
| Kotak Mid Cap Fund | 0.27% | 191 | |
| Mirae Asset Focused Fund | 2.78% | 188 | |
| Mirae Asset Focused Fund | 2.78% | 184 | |
| DSP Healthcare Fund | 3.70% | 142 | |
| Motilal Oswal Multi Cap Fund | 2.83% | 132 | |
| Aditya Birla SL Midcap Fund | 1.85% | 129 | |
| Aditya Birla SL Midcap Fund | 1.85% | 125 | |
| Mirae Asset Large & Midcap Fund | 0.23% | 107 | |
| ICICI Pru Aggressive Hybrid Fund(A | 0.20% | 105 | |
| Mirae Asset Large Cap Fund | 0.24% | 92 | |
| PGIM India Midcap Fund | 0.78% | 87 | |
| HSBC Small Cap Fund | 0.45% | 86 | |
| Aditya Birla SL Large Cap Fund | 0.28% | 82 | |
| HSBC Value Fund | 0.50% | 77 | |
| Franklin India Opportunities Fund | 0.75% | 73 | |
| Kotak Large Cap Fund | 0.65% | 71 | |
| UTI Mid Cap Fund | 0.53% | 68 | |
| Axis Large & Mid Cap Fund | 0.37% | 65 | |
| ICICI Pru Healthcare Fund- | 0.92% | 65 |
Red flags
F-score 7 of 8| look | Share dilution Share count up 10% in a year |
| look | Profit leans on other income Other income was 46% of pre-tax profit in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
No quarterly results published.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
| Artemis Medicare Services Ltd | 5,818 | 50.4 | 14.5 % |
No bulk or block deals on record.
No corporate actions on record.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Manipal Health Enterprises Ltd?
Manipal Health Enterprises Ltd (MANIPALHOS) has a market capitalisation of Rs 98,357 Cr. at the 2026-10-01 close.
What is the P/E ratio of Manipal Health Enterprises Ltd?
Manipal Health Enterprises Ltd trades at a P/E of 111 on trailing twelve-month profit, at the 2026-10-01 close.
What is the 52-week high and low of Manipal Health Enterprises Ltd?
The 52-week high is Rs 815.00 and the 52-week low is Rs 625.45.